These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15178447)

  • 1. Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.
    Trotzier MA; Bronner C; Bathami K; Mathieu E; Abbady AQ; Jeanblanc M; Muller CD; Rochette-Egly C; Mousli M
    Biochem Biophys Res Commun; 2004 Jun; 319(2):590-5. PubMed ID: 15178447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
    Hopfner R; Mousli M; Jeltsch JM; Voulgaris A; Lutz Y; Marin C; Bellocq JP; Oudet P; Bronner C
    Cancer Res; 2000 Jan; 60(1):121-8. PubMed ID: 10646863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition.
    Arima Y; Hirota T; Bronner C; Mousli M; Fujiwara T; Niwa S; Ishikawa H; Saya H
    Genes Cells; 2004 Feb; 9(2):131-42. PubMed ID: 15009091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression.
    Hopfner R; Mousli M; Garnier JM; Redon R; du Manoir S; Chatton B; Ghyselinck N; Oudet P; Bronner C
    Gene; 2001 Mar; 266(1-2):15-23. PubMed ID: 11290415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle.
    Jeanblanc M; Mousli M; Hopfner R; Bathami K; Martinet N; Abbady AQ; Siffert JC; Mathieu E; Muller CD; Bronner C
    Oncogene; 2005 Nov; 24(49):7337-45. PubMed ID: 16007129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.
    Mousli M; Hopfner R; Abbady AQ; Monté D; Jeanblanc M; Oudet P; Louis B; Bronner C
    Br J Cancer; 2003 Jul; 89(1):120-7. PubMed ID: 12838312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of ICBP90 contributes to doxorubicin resistance.
    Wang J; Song Y; Xu S; Zhang Q; Li Y; Tang D; Jin S
    Eur J Pharmacol; 2011 Apr; 656(1-3):33-8. PubMed ID: 21296067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.
    Morgan SE; Beck WT
    Mol Pharmacol; 2001 Feb; 59(2):203-11. PubMed ID: 11160854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR pathway involves ICBP90 gene down-regulation via E2F binding sites.
    Abbady AQ; Bronner C; Bathami K; Muller CD; Jeanblanc M; Mathieu E; Klein JP; Candolfi E; Mousli M
    Biochem Pharmacol; 2005 Aug; 70(4):570-9. PubMed ID: 15964557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.
    Hopfner R; Mousli M; Oudet P; Bronner C
    Anticancer Res; 2002; 22(6A):3165-70. PubMed ID: 12530060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiapoptotic protein ICBP90 is a target for protein kinase 2.
    Bronner C; Trotzier MA; Filhol O; Cochet C; Rochette-Egly C; Schöller-Guinard M; Klein JP; Mousli M
    Ann N Y Acad Sci; 2004 Dec; 1030():355-60. PubMed ID: 15659817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.
    Unoki M; Nishidate T; Nakamura Y
    Oncogene; 2004 Oct; 23(46):7601-10. PubMed ID: 15361834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells.
    Chen MC; Chen CH; Chuang HC; Kulp SK; Teng CM; Chen CS
    Hepatology; 2011 Jan; 53(1):148-59. PubMed ID: 21254166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICBP90 mediates the ERK1/2 signaling to regulate the proliferation of Jurkat T cells.
    Fang Z; Xing F; Bronner C; Teng Z; Guo Z
    Cell Immunol; 2009; 257(1-2):80-7. PubMed ID: 19328461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase IIalpha gene by heat shock.
    Furukawa M; Uchiumi T; Nomoto M; Takano H; Morimoto RI; Naito S; Kuwano M; Kohno K
    J Biol Chem; 1998 Apr; 273(17):10550-5. PubMed ID: 9553115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
    Adachi N; Nomoto M; Kohno K; Koyama H
    Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATF is important to late S phase-dependent regulation of DNA topoisomerase IIalpha gene expression in HeLa cells.
    Son MY; Kim TJ; Kweon KI; Park JI; Park C; Lee YC; No Z; Ahn JW; Yoon WH; Park SK; Lim K; Hwang BD
    Cancer Lett; 2002 Oct; 184(1):81-8. PubMed ID: 12104051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase IIalpha promoter.
    Flores LV; Staples AM; Mackay H; Howard CM; Uthe PB; Sexton JS; Buchmueller KL; Wilson WD; O'Hare C; Kluza J; Hochhauser D; Hartley JA; Lee M
    Chembiochem; 2006 Nov; 7(11):1722-9. PubMed ID: 16991167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinase and protein kinase A signaling pathways stimulate cholecystokinin transcription via activation of cyclic adenosine 3',5'-monophosphate response element-binding protein.
    Hansen TV; Rehfeld JF; Nielsen FC
    Mol Endocrinol; 1999 Mar; 13(3):466-75. PubMed ID: 10077003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation.
    Quan ZW; Yang Y; Li JY; Gong W; Qin YY; Li SG
    Biomed Pharmacother; 2010 Sep; 64(7):451-7. PubMed ID: 20359855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.